Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACBD3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | PTS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | HBE1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | DDX59 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | OLIG3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | GGT5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | UBAC1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |